预测同时的心脏分配和移植后不良结果
Mutlu Mete1, Mehmet U S Ayvaci2, Ahmet B Gungor3
1Department of Information Science, University of North Texas, Denton, Texas, USA.
Kidney international reports
|January 16, 2026
概括
预测心脏移植后的恢复对于同时心脏移植 (SHKT) 决策至关重要. 一个机器学习模型在识别心脏移植 (HT) 后脏不良结果风险的患者方面表现有前途.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植医学 移植医学
- 医疗保健中的机器学习
背景情况:
- 同时心脏移植 (SHKT) 为末期心力衰竭和病患者提供了更好的生存期.
- 预测心脏移植 (HT) 后的恢复是具有挑战性的,并使SHKT的决策更加复杂.
- 准确的预后对于优化器官衰竭联合治疗策略至关重要.
研究的目的:
- 开发和验证一种机器学习模型,以预测心脏移植 (HT) 后一年内不良脏结果.
- 在中度功能衰竭患者的同时心移植 (SHKT) 临床决策过程中提供协助.
- 根据预测的功能来确定可能从SHKT中受益或需要SHKT的HT接受者.
主要方法:
- 在美国 (2018年10月 - 2020年12月) 的成年HT接受者的回顾性队列使用器官采购和移植网络 (OPTN) 数据进行了分析.
- 开发了一个随机森林 (RF) 机器学习算法,使用15个重要变量来预测HT后一年内复合脏不良结果.
- 不良结果包括需要SHKT,需要透析的末期病,严重减少GFR或再移植列表. 模型验证在内部和外部进行.
主要成果:
- 在6579名HT接受者中,13.4%的人经历了不良脏结果或在一年内接受了SHKT.
- 射频模型实现了高特异性 (0.941-0.955) 和负预测值 (0.940-0.955).
- 观察到中度灵敏度 (0.605-0.694) 和正预测值 (0.604-0.680),与强大的类差异化 (c-统计 0.849-0.899).
结论:
- 开发的射频模型在预测心脏移植后脏不良结果方面具有实用性.
- 这种预测工具可以在SHKT的复杂决策过程中补充临床判断.
- 进一步细化可能会提高其在患者选择联合心脏和脏移植方面的作用.
相关概念视频
01:28Kidney Transplant I: Introduction
345
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
345
01:26Kidney Transplant II: Surgical Procedure
320
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
320
01:16Kidney Transplant III: Nursing Management
318
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
318
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
271
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
271
01:20Acute Kidney Injury V: Interprofessional Care
297
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
297
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
209
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
209